Literature DB >> 7026256

Haemodynamic profile of captopril treatment in various forms of hypertension.

J H de Bruyn, A J Man in't Veld, G J Wenting, F H Derkx, M A Schalekamp.   

Abstract

The effects of captopril 450 mg/day for 4 weeks on blood pressure, heart rate, cardiac output and extracellular fluid volume were compared in severe, often drug-resistant hypertension (n = 23), mild to moderate hypertension associated with renal artery stenosis (n = 10) and mild to moderate essential hypertension (n = 20). Plasma renin in the three groups was 52 +/- 19, 58 +/- 17 and 20 +/- 4 microU/ml (mean +/- SEM), respectively. Blood pressure fell by 18 +/- 4%, 21 +/- 2% and 18 +/- 1%. The pressure drop was mainly due to a fall in peripheral vascular resistance. Addition of the diuretic hydrochlorothiazide (25-100 mg/day) caused a further fall in resistance. Despite the vasodilator effect of captopril, reflex cardiostimulation and reactive fluid retention were not observed. In severe hypertension, captopril alone was more effective in lowering blood pressure than combined diuretic-betablocker-vasodilator therapy. Moreover, cardiac output in these patients was higher and resistance was lower after captopril than during combined treatment. Thus, captopril was capable of normalising the abnormal haemodynamic state in patients with essential hypertension, and in hypertension associated with renal artery stenosis. Despite marked differences in pre-treatment plasma renin, the effects of captopril on systemic haemodynamics were similar in all the patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026256     DOI: 10.1007/bf00544593

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  28 in total

1.  A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS.

Authors:  G A ROSE; W W HOLLAND; E A CROWLEY
Journal:  Lancet       Date:  1964-02-08       Impact factor: 79.321

2.  Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients.

Authors:  D B Case; S A Atlas; J H Laragh; J E Sealey; P A Sullivan; D N McKinstry
Journal:  Prog Cardiovasc Dis       Date:  1978 Nov-Dec       Impact factor: 8.194

3.  Quantitative radiocardiography by single-probe counting using 99mtechnetium albumin: clinical application in follow-up studies.

Authors:  A J Man in 't Veld; G J Wenting; R P Verhoeven; M A Schalekamp
Journal:  Neth J Med       Date:  1978       Impact factor: 1.422

4.  Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.

Authors:  C I Johnston; J A Millar; B P McGrath; P G Matthews
Journal:  Lancet       Date:  1979-09-08       Impact factor: 79.321

5.  Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.

Authors:  G Leonetti; L Terzoli; C Sala; C Bianchini; L Sernesi; A Zanchetti
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

6.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04

7.  Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.

Authors:  B Waeber; H R Brunner; D B Brunner; A L Curtet; G A Turini; H Gavras
Journal:  Hypertension       Date:  1980 Mar-Apr       Impact factor: 10.190

8.  Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect.

Authors:  M Tree; J J Morton
Journal:  Clin Sci (Lond)       Date:  1980-12       Impact factor: 6.124

Review 9.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

10.  Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.

Authors:  S L Swartz; G H Williams; N K Hollenberg; L Levine; R G Dluhy; T J Moore
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more
  4 in total

1.  Splint renal function after captopril in unilateral renal artery stenosis.

Authors:  G J Wenting; H L Tan-Tjiong; F H Derkx; J H de Bruyn; A J Man in't Veld; M A Schalekamp
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24

2.  Dose finding studies with imidapril--a new ACE inhibitor.

Authors:  M J Vandenburg; E M Mackay; I Dews; T Pullan; S Brugier
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

3.  Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension.

Authors:  O O Thomsen; H Danielsen; S S Sørensen; E B Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.

Authors:  G J Wenting; A J Man in't veld; A J Woittiez; F Boomsma; K Laird-Meeter; M L Simoons; P G Hugenholtz; M A Schalekamp
Journal:  Br Heart J       Date:  1983-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.